On April 8, 2025, Aditxt, Inc. invested $1.5 million in Evofem Biosciences, acquiring a convertible note of $2.3 million and a warrant for 149.8 million shares, with terms extending to 2028.
AI Assistant
ADITXT INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.